Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Cullgen, Daewoong, Daiichi Sankyo, Eucure, Everest Medicines, Immvira, Innocare, Moderna, Novavax, SK, Tracon.